AMERICAN CENTURY COMPANIES INC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERICAN CENTURY COMPANIES INC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$1,515,000
+48.7%
40,584
+1.8%
0.00%0.0%
Q1 2021$1,019,000
+365.3%
39,865
+301.2%
0.00%
Q4 2020$219,000
-40.2%
9,937
-40.2%
0.00%
Q4 2019$366,000
-81.8%
16,618
-88.1%
0.00%
-100.0%
Q3 2019$2,006,000
-34.5%
139,683
-28.2%
0.00%
-33.3%
Q2 2019$3,064,000194,5300.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,705,392$43,607,0007.88%
Bain Capital Life Sciences Investors, LLC 3,080,237$78,762,0004.46%
DAFNA Capital Management LLC 587,756$15,029,0003.57%
RTW INVESTMENTS, LP 7,463,291$190,836,0002.98%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$5,114,0002.79%
Evolutionary Tree Capital Management, LLC 122,473$3,132,0001.85%
Parkman Healthcare Partners LLC 303,268$7,755,0001.80%
Eagle Health Investments LP 161,125$4,120,0001.62%
BRIDGER MANAGEMENT, LLC 588,910$15,058,0001.41%
Woodline Partners LP 1,777,000$45,438,0001.01%
View complete list of DICERNA PHARMACEUTICALS INC shareholders